Discovery of long-acting angiotensin 1-7, apelin-13, and bispecific mimetics for the treatment of cardiovascular and metabolic diseases

類似資料

• Anti-emicizumab antibodies and their relevance in clinical practice
  著者:: Carla Valsecchi, 等
  出版事項: (2026-01-01)
• Comparative Investigation of Thromboelastometry and Thrombin Generation for Patients Receiving Direct Oral Anticoagulants or Vitamin K Antagonists
  著者:: Armando Tripodi, 等
  出版事項: (2024-11-01)
• Impact of blood centrifugation on the parameters of thrombin generation assay revisited to look for possible revision of the current guidance
  著者:: Erica Scalambrino, 等
  出版事項: (2025-07-01)
• No correlation between thrombin generation and emicizumab levels: implications for monitoring emicizumab therapy
  著者:: Konrad van der Zwet, 等
  出版事項: (2025-01-01)
• Surgical Experience from the STASEY Study of Emicizumab Prophylaxis in People with Hemophilia A with Factor VIII Inhibitors
  著者:: Giancarlo Castaman, 等
  出版事項: (2024-01-01)